SCHEMBL12912518

SCHEMBL12912518

c1ccc2c(-c3nc4ccccc4n3-c3ccc(-c4ccc5ccc6cccc7ccc4c5c67)cc3)cccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 5/20 0.44
▸ ESR1 P03372 4/20 0.44
▸ RAB9A P51151 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ GRIA1 P42261 1/20 0.42
▸ CACNG8 Q8WXS5 1/20 0.42
▸ CACNG2 Q9Y698 1/20 0.42
▸ FLT3 P36888 3/20 0.39
▸ PTGS2 P35354 1/20 0.38
▸ BMX P51813 2/20 0.36
▸ ENPP3 O14638 1/20 0.36
▸ ENPP1 P22413 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ PRKACA P17612 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12912523 0.90 ESR2 (0.52) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL25769038 0.89 ESR2 (0.53) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL9976944 0.88 ESR1 (0.56) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL12611887 0.87 RECQL (0.46) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL9976946 0.87 ESR1 (0.55) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL9976949 0.87 ESR1 (0.55) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL10041759 0.87 ESR1 (0.51) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL25112990 0.86 RECQL (0.48) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL12912481 0.86 MAPK10 (0.47) ESR2ESR1RAB9ARECQLGRIA1
SCHEMBL12912486 0.86 ESR1 (0.48) ESR2ESR1RAB9AGRIA1CACNG8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NUDC, TYR, NUDT1 ESR2 1585/4885ESR1 563/4885RAB9A 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback